Story perspectives

GE HealthCare Surpasses Q4 Earnings Estimates Amid Volatile Stock

2/14/2025

48 8

Summary

Story summary

GE HealthCare Technologies Inc. reported Q4 2024 adjusted EPS of $1.45, surpassing estimates by 15.1% and up 22.9% year-over-year.
Total revenues reached $5.32 billion, reflecting a 2% increase, fueled by robust U.S. market performance.
For 2025, the company projects adjusted EPS between $4.61 and $4.75, with organic revenue growth of 2-3%.
Despite positive earnings, GE HealthCare's stock remains volatile due to cautious investor sentiment about future growth.

History

Historical Context

GE HealthCare's strong Q4 2024 performance echoes the industry's historical growth amid healthcare reforms. The 2010 Affordable Care Act aimed to expand access and reduce costs, driving innovation and investment. Today's cautious investor sentiment reflects past market volatility, reminiscent of the 2008 financial crisis's impact on healthcare stocks.

1 of 2

Story summary

GE HealthCare Technologies Inc. reported Q4 2024 adjusted EPS of $1.45, surpassing estimates by 15.1% and up 22.9% year-over-year.
Total revenues reached $5.32 billion, reflecting a 2% increase, fueled by robust U.S. market performance.
For 2025, the company projects adjusted EPS between $4.61 and $4.75, with organic revenue growth of 2-3%.
Despite positive earnings, GE HealthCare's stock remains volatile due to cautious investor sentiment about future growth.

1 / 2